Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
How should I treat a patient with severe and symptomatic aortic stenosis who is rejected for surgical and transfemoral valve replacement and in whom a transapical implantation was aborted? Percutaneous reconstruction of the right ilio-femoral tract with balloon angioplasty followed by the implantation of self-expanding stents.
de Jaegere PP, van Dijk LC, van Sambeek MR, Kappetein AP, Orellana Ramos FJ, Maugenest A, de Ronde-Tilmans M, Serruys PW. de Jaegere PP, et al. Among authors: de ronde tilmans m. EuroIntervention. 2008 Aug;4(2):292-6. doi: 10.4244/eijv4i2a50. EuroIntervention. 2008. PMID: 19110797
Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries.
Oemrawsingh RM, Garcia-Garcia HM, van Geuns RJ, Lenzen MJ, Simsek C, de Boer SP, Van Mieghem NM, Regar E, de Jaegere PP, Akkerhuis KM, Ligthart JM, Zijlstra F, Serruys PW, Boersma E. Oemrawsingh RM, et al. Among authors: de boer sp, de jaegere pp. EuroIntervention. 2016 Aug 20;12(6):734-9. doi: 10.4244/EIJV12I6A118. EuroIntervention. 2016. PMID: 27542785 Free article. Clinical Trial.
Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents.
Tsuchida K, Ong AT, Aoki J, van Mieghem CA, Rodriguez-Granillo GA, Valgimigli M, Sianos G, Regar E, McFadden EP, van der Giessen WJ, de Feyter PJ, de Jaegere PP, van Domburg RT, Serruys PW. Tsuchida K, et al. Among authors: de jaegere pp, de feyter pj. Am J Cardiol. 2005 Aug 1;96(3):395-8. doi: 10.1016/j.amjcard.2005.03.084. Am J Cardiol. 2005. PMID: 16054466
Transcatheter aortic valve implantation. Where are we?
de Jaegere PP, Ruiz C, Bonhoeffer P, Vahanian A, Marco J, Serruys PW. de Jaegere PP, et al. EuroIntervention. 2009 Jun;5(2):169-71. doi: 10.4244/eijv5i2a27. EuroIntervention. 2009. PMID: 19527976 No abstract available.
Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction.
Tzikas A, van Dalen BM, Van Mieghem NM, Gutierrez-Chico JL, Nuis RJ, Kauer F, Schultz C, Serruys PW, de Jaegere PP, Geleijnse ML. Tzikas A, et al. Among authors: de jaegere pp. Am J Cardiol. 2011 Jan 15;107(2):285-9. doi: 10.1016/j.amjcard.2010.09.015. Epub 2010 Dec 2. Am J Cardiol. 2011. PMID: 21129715
283 results